HR-2125 : Still Just a Bill

Quit Because of COVID-19 Act

This bill provides for Medicaid and Children's Health Insurance Program (CHIP) coverage of certain tobacco cessation services.

Specifically, the bill provides for coverage, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines. It also applies a 100% Federal Medical Assistance Percentage (i.e., federal matching rate) for such items and services during the public health emergency relating to COVID-19 and for two years after the emergency period ends.

Action Timeline

Action DateTypeTextSource
2021-03-24CommitteeReferred to the Subcommittee on Health.House committee actions
2021-03-23IntroReferralReferred to the House Committee on Energy and Commerce.House floor actions
2021-03-23IntroReferralIntroduced in HouseLibrary of Congress

Sponsor :

Rep. Blunt Rochester, Lisa [D-DE-At Large]
See Cosponsors

Policy Area :

Health
See Subjects
  • Cardiovascular and respiratory health
  • Child health
  • Drug therapy
  • Drug, alcohol, tobacco use
  • Emergency medical services and trauma care
  • Health care costs and insurance
  • Health care coverage and access
  • Health promotion and preventive care
  • Infectious and parasitic diseases
  • Medicaid
  • Medical tests and diagnostic methods
  • Poverty and welfare assistance
  • Prescription drugs
  • State and local government operations
  • U.S. territories and protectorates

Related Bills

See Related Bills